61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Stryker Corp
Closed
Sector Healthcare
392.91 1.31
Overview
Share price change
24h
Min
384.54
Max
393.2
Income | 9M 834M |
|---|---|
Sales | 90M 5.5B |
P/E Sector Avg | 40.27 94.998 |
EPS | 2.87 |
Dividend yield | 0.886 |
Profit margin | 15.191 |
Employees | 52,000 |
EBITDA | 128M 1.4B |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +3.27 upside |
Dividend yield Sector Avg | 0.89% 2.40% |
|---|---|
Next Earnings | 28 Jan 2025 |
Next Dividend date | 29 Jan 2025 |
Next Ex Dividend date | 26 Dec 2024 |
Market Cap | 8.7B 147B |
|---|---|
Previous open | 391.6 |
Previous close | 392.91 |
News Sentiment
By Acuity
24%
76%
68 / 392 Healthcare
Technical Score
By Trading Central
Confidence
Bearish Evidence
Stryker Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Stryker Corp Forecast
Price Target
By TipRanks
3.27% upside
12 Months Forecast
Average 400.85 USD 3.27%
High 420 USD
Low 370 USD
Based on 22 Wall Street analysts offering 12 month price targets forStryker Corp - Dist in the last 3 months.
Sentiment
By Acuity
68 / 392 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Stryker Corp
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. Its segments include Orthopaedics, MedSurg, Neurotechnology and Spine. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment, intensive care disposable products; reprocessed and remanufactured medical devices, and other related products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. Its products include implants, which are used in joint replacement and trauma surgeries, and other products. It offers musculoskeletal care and sensor technology for total joint replacement.
